{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T07:40:37Z","timestamp":1789890037564,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.biochi.2024.09.011","type":"journal-article","created":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T01:07:26Z","timestamp":1726880846000},"page":"158-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The Barnase-Barstar-based pre-targeting strategy for enhanced antitumor therapy in\u00a0vivo"],"prefix":"10.1016","volume":"228","author":[{"given":"G.M.","family":"Proshkina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.I.","family":"Shramova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.B.","family":"Mirkasyimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. Yu","family":"Griaznova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.V.","family":"Konovalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.","family":"Schulga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Deyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biochi.2024.09.011_bib1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41392-021-00868-x","article-title":"Emerging new therapeutic antibody derivatives for cancer treatment","volume":"7","author":"Jin","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.biochi.2024.09.011_bib2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1146\/annurev-pharmtox-010611-134654","article-title":"Designed ankyrin repeat proteins (DARPins): binding proteins for research, diagnostics, and therapy","volume":"55","author":"Pluckthun","year":"2015","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.biochi.2024.09.011_bib3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.32607\/actanaturae.11545","article-title":"Artificial scaffold polypeptides as an efficient tool for the targeted delivery of nanostructures in\u00a0vitro and in\u00a0vivo","volume":"14","author":"Shipunova","year":"2022","journal-title":"Acta Naturae"},{"issue":"3","key":"10.1016\/j.biochi.2024.09.011_bib4","doi-asserted-by":"crossref","DOI":"10.1070\/RCR5034","article-title":"Targeted nuclear medicine. Seek and destroy","volume":"91","author":"Tolmachev","year":"2022","journal-title":"Russ. Chem. Rev."},{"issue":"1","key":"10.1016\/j.biochi.2024.09.011_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1070\/RCR4459","article-title":"Man-made antibodies and immunoconjugates with desired properties: function optimization using structural engineering","volume":"84","author":"Deyev","year":"2015","journal-title":"Russ. Chem. Rev."},{"issue":"6025","key":"10.1016\/j.biochi.2024.09.011_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/316265a0","article-title":"Antibodies against metal chelates","volume":"316","author":"Reardan","year":"1985","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.biochi.2024.09.011_bib7","first-page":"1294","article-title":"Investigations of avidin and biotin for imaging applications","volume":"28","author":"Hnatowich","year":"1987","journal-title":"J.\u00a0Nucl. Med."},{"issue":"10","key":"10.1016\/j.biochi.2024.09.011_bib8","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2967\/jnumed.117.189944","article-title":"Pretargeted imaging and therapy","volume":"58","author":"Altai","year":"2017","journal-title":"J.\u00a0Nucl. Med."},{"issue":"5","key":"10.1016\/j.biochi.2024.09.011_bib9","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1021\/acs.bioconjchem.2c00087","article-title":"Clickable albumin nanoparticles for pretargeted drug delivery toward PD-L1 overexpressing tumors in combination immunotherapy","volume":"33","author":"Gerke","year":"2022","journal-title":"Bioconjugate Chem."},{"issue":"3","key":"10.1016\/j.biochi.2024.09.011_bib10","article-title":"SQ3370 activates cytotoxic drug via click chemistry at tumor and elicits sustained responses in injected & non-injected lesions","volume":"4","author":"Srinivasan","year":"2021","journal-title":"Adv. Ther."},{"issue":"12","key":"10.1016\/j.biochi.2024.09.011_bib11","doi-asserted-by":"crossref","first-page":"14004","DOI":"10.1021\/acsami.1c01259","article-title":"Bioorthogonal pretargeting strategy for anchoring activatable photosensitizers on plasma membranes for effective photodynamic therapy","volume":"13","author":"Wei","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"35","key":"10.1016\/j.biochi.2024.09.011_bib12","doi-asserted-by":"crossref","first-page":"12722","DOI":"10.1073\/pnas.1413027111","article-title":"Refilling drug delivery depots through the blood","volume":"111","author":"Brudno","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.biochi.2024.09.011_bib13","doi-asserted-by":"crossref","first-page":"602","DOI":"10.2183\/pjab.95.041","article-title":"Cupid and Psyche system for the diagnosis and treatment of advanced cancer","volume":"95","author":"Sugiyama","year":"2019","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"issue":"1","key":"10.1016\/j.biochi.2024.09.011_bib14","doi-asserted-by":"crossref","first-page":"6982","DOI":"10.1038\/s41598-019-43416-y","article-title":"Enhancement of HIFU ablation by sonosensitizer-loading liquid fluorocarbon nanoparticles with pre-targeting in a mouse model","volume":"9","author":"Zhang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biochi.2024.09.011_bib15","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.11486","article-title":"Biotin-streptavidin-guided two-step pretargeting approach using PLGA for molecular ultrasound imaging and chemotherapy for ovarian cancer","volume":"9","author":"Zhou","year":"2021","journal-title":"PeerJ"},{"issue":"1","key":"10.1016\/j.biochi.2024.09.011_bib16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12951-020-00752-w","article-title":"Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor activity","volume":"19","author":"Ho","year":"2021","journal-title":"J.\u00a0Nanobiotechnol."},{"key":"10.1016\/j.biochi.2024.09.011_bib17","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.3389\/fphar.2018.01476","article-title":"A\u00a0revisit to the pretargeting concept-A target conversion","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biochi.2024.09.011_bib18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jconrel.2021.11.001","article-title":"Barnase\u2217Barstar-guided two-step targeting approach for drug delivery to tumor cells in\u00a0vivo","volume":"340","author":"Shramova","year":"2021","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.biochi.2024.09.011_bib19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0076-6879(01)41179-7","article-title":"Barnase-barstar interaction","volume":"341","author":"Hartley","year":"2001","journal-title":"Methods Enzymol."},{"issue":"12","key":"10.1016\/j.biochi.2024.09.011_bib20","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/nbt916","article-title":"Design of multivalent complexes using the barnase\u2217barstar module","volume":"21","author":"Deyev","year":"2003","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.biochi.2024.09.011_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15030833","article-title":"Targeted two-step delivery of oncotheranostic nano-PLGA for HER2-positive tumor imaging and therapy in\u00a0vivo: improved effectiveness compared to one-step strategy","volume":"15","author":"Shipunova","year":"2023","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.biochi.2024.09.011_bib22","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/sj.bjc.6603581","article-title":"In ovarian cancer the prognostic influence of HER2\/neu is not dependent on the CXCR4\/SDF-1 signalling pathway","volume":"96","author":"Pils","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.biochi.2024.09.011_bib23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/jcp.2011.090274","article-title":"EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis","volume":"64","author":"Spizzo","year":"2011","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.biochi.2024.09.011_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1515\/med-2017-0007","article-title":"Clinicopathology of EpCAM and EGFR in human epithelial ovarian carcinoma","volume":"12","author":"Zheng","year":"2017","journal-title":"Open Med."},{"issue":"4","key":"10.1016\/j.biochi.2024.09.011_bib25","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jmb.2007.03.028","article-title":"A\u00a0designed ankyrin repeat protein evolved to picomolar affinity to Her2","volume":"369","author":"Zahnd","year":"2007","journal-title":"J.\u00a0Mol. Biol."},{"issue":"5","key":"10.1016\/j.biochi.2024.09.011_bib26","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.jmb.2008.07.085","article-title":"Efficient selection of DARPins with sub-nanomolar affinities using SRP phage display","volume":"382","author":"Steiner","year":"2008","journal-title":"J.\u00a0Mol. Biol."},{"issue":"4","key":"10.1016\/j.biochi.2024.09.011_bib27","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jmb.2011.09.016","article-title":"DARPins recognizing the tumor-associated antigen EpCAM selected by phage and ribosome display and engineered for multivalency","volume":"413","author":"Stefan","year":"2011","journal-title":"J.\u00a0Mol. Biol."},{"issue":"7","key":"10.1016\/j.biochi.2024.09.011_bib28","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nrc1891","article-title":"Immunotoxin therapy of cancer","volume":"6","author":"Pastan","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.biochi.2024.09.011_bib29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.32607\/20758251-2017-9-3-103-107","article-title":"The effect of the targeted recombinant toxin DARPin-PE40 on the dynamics of HER2-positive tumor growth","volume":"9","author":"Sokolova","year":"2017","journal-title":"Acta Naturae"},{"issue":"1","key":"10.1016\/j.biochi.2024.09.011_bib30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pep.2005.01.016","article-title":"Protein production by auto-induction in high density shaking cultures","volume":"41","author":"Studier","year":"2005","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.biochi.2024.09.011_bib31","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejpb.2018.06.026","article-title":"Selective staining and eradication of cancer cells by protein-carrying DARPin-functionalized liposomes","volume":"130","author":"Deyev","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.biochi.2024.09.011_bib32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.32607\/20758251-2016-8-4-118-123","article-title":"Flavoprotein miniSOG cytotoxisity can Be induced by bioluminescence resonance energy transfer","volume":"8","author":"Shramova","year":"2016","journal-title":"Acta Naturae"},{"issue":"1","key":"10.1016\/j.biochi.2024.09.011_bib33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41377-022-00729-4","article-title":"Genetically encoded BRET-activated photodynamic therapy for the treatment of deep-seated tumors","volume":"11","author":"Shramova","year":"2022","journal-title":"Light Sci. Appl."},{"key":"10.1016\/j.biochi.2024.09.011_bib34","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3389\/fimmu.2020.00791","article-title":"Immunogenicity of protein therapeutics: a lymph node perspective","volume":"11","author":"Fu","year":"2020","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.biochi.2024.09.011_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20102399","article-title":"HER2-Specific targeted toxin DARPin-LoPE: immunogenicity and antitumor effect on intraperitoneal ovarian cancer xenograft model","volume":"20","author":"Sokolova","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biochi.2024.09.011_bib36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JCO.20.00596","article-title":"First-in-Human phase I study of MP0250, a first-in-class DARPin drug candidate targeting VEGF and HGF, in patients with advanced solid tumors","volume":"39","author":"Baird","year":"2021","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.biochi.2024.09.011_bib37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2016.05.020","article-title":"Recombinant targeted toxin based on HER2-specific DARPin possesses a strong selective cytotoxic effect in\u00a0vitro and a potent antitumor activity in\u00a0vivo","volume":"233","author":"Sokolova","year":"2016","journal-title":"J.\u00a0Contr. Release"},{"issue":"2","key":"10.1016\/j.biochi.2024.09.011_bib38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1158\/1535-7163.MCT-13-0523","article-title":"Increasing the antitumor effect of an EpCAM-targeting fusion toxin by facile click PEGylation","volume":"13","author":"Simon","year":"2014","journal-title":"Mol. Cancer Therapeut."},{"issue":"24","key":"10.1016\/j.biochi.2024.09.011_bib39","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2200200119","article-title":"Intraductal administration of transferrin receptor-targeted immunotoxin clears ductal carcinoma in situ in mouse models of breast cancer-a preclinical study","volume":"119","author":"Wang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.biochi.2024.09.011_bib40","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1038\/s41375-018-0210-1","article-title":"Moxetumomab pasudotox in relapsed\/refractory hairy cell leukemia","volume":"32","author":"Kreitman","year":"2018","journal-title":"Leukemia"}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908424002219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908424002219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T15:43:42Z","timestamp":1735314222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908424002219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":40,"alternative-id":["S0300908424002219"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2024.09.011","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Barnase-Barstar-based pre-targeting strategy for enhanced antitumor therapy in\u00a0vivo","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2024.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. and Soci\u00e9t\u00e9 Fran\u00e7aise de Biochimie et Biologie Mol\u00e9culaire (SFBBM). All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}